Re: ZHCLF trades on the OTC
in response to
by
posted on
Jan 18, 2021 01:06PM
Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials
"If the end game for Zenith is a buyout and they come to an agreement to sell, the OTC shares are entitiled to no payout."
I don't believe that to be the case.
IMO ... Koo